Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Lories

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Acta Clinica Belgica|February 19, 1999
[Functional mechanisms of intravenous immunoglobulins]R J Lories, D Blockmans
Clinical Rheumatology|March 20, 2001
Osteoprotegerin and osteoprotegerin-ligand balance: a new paradigm in bone metabolism providing new therapeutic targetsR J Lories, F P Luyten
Osteoarthritis and Cartilage|April 12, 2020
Cracking the code on the innate immune program in OAT M Griffin, R J Lories
Clinical and Experimental Rheumatology|October 14, 2009
Differences in pathophysiology between rheumatoid arthritis and ankylosing spondylitisR J Lories, D L P Baeten
Osteoarthritis and Cartilage|December 3, 2014
Loss of Frzb and Sfrp1 differentially affects joint homeostasis in instability-induced osteoarthritisS Thysen, F P Luyten, R J Lories
Osteoarthritis and Cartilage|July 23, 2019
Exostosin-1 enhances canonical Wnt signaling activity during chondrogenic differentiationX Wang, F M F Cornelis, R J Lories, et al.
Acta Clinica Belgica|September 12, 2000
The use of polyclonal intravenous immunoglobulins in the prevention and treatment of infectious diseasesR J Lories, J A Maertens, J L Ceuppens, et al.
Clinical and Experimental Rheumatology|November 27, 2008
Animal models in systemic sclerosisV Rogai, R J Lories, S Guiducci, et al.
Rheumatology (Oxford, England)|November 17, 2005
Evidence for a differential association of the Arg200Trp single-nucleotide polymorphism in FRZB with hip osteoarthritis and osteoporosisR J Lories, S Boonen, J Peeters, et al.
Annals of the Rheumatic Diseases|May 14, 2004
Polyclonal immunoglobulins for intravenous use induce interleukin 10 release in vivo and in vitroR J Lories, M Casteels-Van Daele, J L Ceuppens, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Acta Clinica Belgica|February 19, 1999
[Functional mechanisms of intravenous immunoglobulins]R J Lories, D Blockmans
Clinical Rheumatology|March 20, 2001
Osteoprotegerin and osteoprotegerin-ligand balance: a new paradigm in bone metabolism providing new therapeutic targetsR J Lories, F P Luyten
Osteoarthritis and Cartilage|April 12, 2020
Cracking the code on the innate immune program in OAT M Griffin, R J Lories
Clinical and Experimental Rheumatology|October 14, 2009
Differences in pathophysiology between rheumatoid arthritis and ankylosing spondylitisR J Lories, D L P Baeten
Osteoarthritis and Cartilage|December 3, 2014
Loss of Frzb and Sfrp1 differentially affects joint homeostasis in instability-induced osteoarthritisS Thysen, F P Luyten, R J Lories
Osteoarthritis and Cartilage|July 23, 2019
Exostosin-1 enhances canonical Wnt signaling activity during chondrogenic differentiationX Wang, F M F Cornelis, R J Lories, et al.
Acta Clinica Belgica|September 12, 2000
The use of polyclonal intravenous immunoglobulins in the prevention and treatment of infectious diseasesR J Lories, J A Maertens, J L Ceuppens, et al.
Clinical and Experimental Rheumatology|November 27, 2008
Animal models in systemic sclerosisV Rogai, R J Lories, S Guiducci, et al.
Rheumatology (Oxford, England)|November 17, 2005
Evidence for a differential association of the Arg200Trp single-nucleotide polymorphism in FRZB with hip osteoarthritis and osteoporosisR J Lories, S Boonen, J Peeters, et al.
Annals of the Rheumatic Diseases|May 14, 2004
Polyclonal immunoglobulins for intravenous use induce interleukin 10 release in vivo and in vitroR J Lories, M Casteels-Van Daele, J L Ceuppens, et al.
Pageof 2